These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 26311741)
1. Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer. Kim HS; Yoon G; Ryu JY; Cho YJ; Choi JJ; Lee YY; Kim TJ; Choi CH; Song SY; Kim BG; Bae DS; Lee JW Oncotarget; 2015 Sep; 6(29):26746-56. PubMed ID: 26311741 [TBL] [Abstract][Full Text] [Related]
2. Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma. Li W; Li J; Wang Y; Zhang K; Li N; Tian Z; Ni B; Wang H; Ruan Z Oncotarget; 2016 Dec; 7(49):80586-80598. PubMed ID: 27811359 [TBL] [Abstract][Full Text] [Related]
3. Sphingosine kinase 1 promotes tumor progression and confers malignancy phenotypes of colon cancer by regulating the focal adhesion kinase pathway and adhesion molecules. Liu SQ; Su YJ; Qin MB; Mao YB; Huang JA; Tang GD Int J Oncol; 2013 Feb; 42(2):617-26. PubMed ID: 23232649 [TBL] [Abstract][Full Text] [Related]
4. Increased Sphingosine Kinase 1 Expression Predicts Distant Metastasis and Poor Outcome in Patients With Colorectal Cancer. Bae GE; DO SI; Kim K; Park JH; Cho S; Kim HS Anticancer Res; 2019 Feb; 39(2):663-670. PubMed ID: 30711943 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer. Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253 [TBL] [Abstract][Full Text] [Related]
6. [Relationship between sphingosine kinase 1 expression and tumor invasion, metastasis and prognosis in gastric cancer]. Zhuge YH; Tao HQ; Wang YY Zhonghua Yi Xue Za Zhi; 2011 Oct; 91(39):2765-8. PubMed ID: 22322056 [TBL] [Abstract][Full Text] [Related]
7. B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer. Zhang W; Hou T; Niu C; Song L; Zhang Y PLoS One; 2015; 10(12):e0144360. PubMed ID: 26709519 [TBL] [Abstract][Full Text] [Related]
8. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer. Xu R; Hu J; Zhang T; Jiang C; Wang HY Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037 [TBL] [Abstract][Full Text] [Related]
9. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma. Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716 [TBL] [Abstract][Full Text] [Related]
10. The impact of sphingosine kinase 1 on the prognosis of hepatocellular carcinoma patients with portal vein tumor thrombus. Shi J; He YY; Sun JX; Guo WX; Li N; Xue J; Cheng SQ Ann Hepatol; 2015; 14(2):198-206. PubMed ID: 25671829 [TBL] [Abstract][Full Text] [Related]
11. Up-regulation and tumor-promoting role of SPHK1 were attenuated by miR-330-3p in gastric cancer. Wang Z; Qu H; Gong W; Liu A IUBMB Life; 2018 Nov; 70(11):1164-1176. PubMed ID: 30281914 [TBL] [Abstract][Full Text] [Related]
12. C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer. Zhang W; Ou J; Lei F; Hou T; Wu S; Niu C; Xu L; Zhang Y Tumour Biol; 2016 Jan; 37(1):369-79. PubMed ID: 26219895 [TBL] [Abstract][Full Text] [Related]
13. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients. Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190 [TBL] [Abstract][Full Text] [Related]
14. Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients. Li W; Yu CP; Xia JT; Zhang L; Weng GX; Zheng HQ; Kong QL; Hu LJ; Zeng MS; Zeng YX; Li M; Li J; Song LB Clin Cancer Res; 2009 Feb; 15(4):1393-9. PubMed ID: 19228740 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor receptor and sphingosine kinase are prognostic and therapeutic targets in breast cancer. Ochnik AM; Baxter RC BMC Cancer; 2017 Dec; 17(1):820. PubMed ID: 29207959 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of cystic fibrosis transmembrane conductance regulator (CFTR) is associated with human cervical cancer malignancy, progression and prognosis. Peng X; Wu Z; Yu L; Li J; Xu W; Chan HC; Zhang Y; Hu L Gynecol Oncol; 2012 May; 125(2):470-6. PubMed ID: 22366595 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance and functions of microRNA-93/CDKN1A axis in human cervical cancer. Zhang X; Li F; Zhu L Life Sci; 2018 Sep; 209():242-248. PubMed ID: 30098344 [TBL] [Abstract][Full Text] [Related]
18. Significance of sphingosine kinase 1 expression in feline mammary tumors. Chang YC; Chuang HL; Yin JH; Liao JW; Chen TH; Wang YC BMC Vet Res; 2019 May; 15(1):155. PubMed ID: 31101115 [TBL] [Abstract][Full Text] [Related]
19. Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition. Sinha UK; Schorn VJ; Hochstim C; Chinn SB; Zhu S; Masood R Head Neck; 2011 Feb; 33(2):178-88. PubMed ID: 20848438 [TBL] [Abstract][Full Text] [Related]